IGFBP7 and acute kidney injury: Can measuring the cell-cycle arrest biomarkers tissue inhibitor of metalloproteinases 2 (TIMP-2) and insulinlike growth factor binding protein 7 (IGFBP7) enhance acute kidney injury (AKI) staging using a recently proposed framework?